Physician profile
Mehran Attari
NPI 1760447148
$9,218.90
in general payments reported to CMS, 2019-2025
27 companies · $2,695 in 2025
The $2,695 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $380 · 2021: $816 · 2022: $1,626 · 2023: $1,228 · 2024: $1,876 · 2025: $2,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,343 · Travel and Lodging: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,342.77 |
| Travel and Lodging | $2,456.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,252.24 | 2021-2025 | Evera Mri Xt Dr Surescan, Affera Mapping System, Arctic Front Advance |
| Abbott Laboratories | $1,927.75 | 2022-2025 | Aveir, Ensite Precision, Amplatzer Talisman |
| Biosense Webster, INC. | $1,193.36 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Soundstar |
| Boston Scientific Corporation | $1,100.82 | 2021-2025 | Emblem Mri S-Icd, Watchman Access System, Rhythmia Mapping System |
| Atricure, INC. | $514.39 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $343.89 | 2019-2022 | |
| Abiomed | $259.19 | 2019-2025 | Impella |
| Biotronik INC. | $219.05 | 2021-2025 | Acticor 7 Vr-T Dx |
| Edwards Lifesciences Corporation | $198.99 | 2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $197.45 | 2019-2025 | |
| Cardiva Medical, INC. | $130.88 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Zoll Respicardia, INC. | $120.22 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.01 | 2021-2024 | Lifevest |
| Amgen INC. | $111.80 | 2019-2025 | Repatha |
| Medtronic Vascular, INC. | $105.11 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.28 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.29 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.96 | 2021-2023 | |
| Bardy Diagnostics, INC. | $40.00 | 2019-2021 | |
| Philips North America LLC | $37.82 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $36.66 | 2019-2023 | Farxiga |
| Cardiovascular Systems INC. | $32.09 | 2019-2021 | |
| Coala Life INC | $27.85 | 2022 | |
| Merck Sharp & Dohme LLC | $27.76 | 2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $18.48 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $15.91 | 2020 | |
| Terumo Medical Corporation | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehran Attari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.